Ekso Bionics Holdings, Inc. (EKSO)
USD 0.63
(-11.99%)
USD 0.63
(-11.99%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 18.27 Million USD | 41.57% |
| 2022 | 12.91 Million USD | 14.81% |
| 2021 | 11.24 Million USD | 26.62% |
| 2020 | 8.88 Million USD | -36.18% |
| 2019 | 13.91 Million USD | 22.81% |
| 2018 | 11.33 Million USD | 54.11% |
| 2017 | 7.35 Million USD | -48.29% |
| 2016 | 14.22 Million USD | 64.2% |
| 2015 | 8.66 Million USD | 62.59% |
| 2014 | 5.32 Million USD | 61.33% |
| 2013 | 3.3 Million USD | 22.03% |
| 2012 | 2.7 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 4.95 Million USD | 31.79% |
| 2024 Q3 | 4.12 Million USD | -16.59% |
| 2024 Q1 | 3.75 Million USD | -22.51% |
| 2023 Q3 | 4.6 Million USD | -2.04% |
| 2023 Q4 | 4.84 Million USD | 5.21% |
| 2023 FY | 18.27 Million USD | 41.57% |
| 2023 Q1 | 4.12 Million USD | 16.08% |
| 2023 Q2 | 4.7 Million USD | 14.1% |
| 2022 Q4 | 3.55 Million USD | 6.67% |
| 2022 FY | 12.91 Million USD | 14.81% |
| 2022 Q1 | 2.56 Million USD | -37.02% |
| 2022 Q3 | 3.32 Million USD | -3.92% |
| 2022 Q2 | 3.46 Million USD | 34.98% |
| 2021 Q4 | 4.07 Million USD | 33.68% |
| 2021 Q3 | 3.04 Million USD | 37.9% |
| 2021 Q2 | 2.21 Million USD | 15.76% |
| 2021 Q1 | 1.91 Million USD | -15.26% |
| 2021 FY | 11.24 Million USD | 26.62% |
| 2020 Q2 | 2.26 Million USD | 54.22% |
| 2020 Q4 | 2.25 Million USD | -22.2% |
| 2020 Q3 | 2.89 Million USD | 27.96% |
| 2020 FY | 8.88 Million USD | -36.18% |
| 2020 Q1 | 1.46 Million USD | -60.53% |
| 2019 Q3 | 3.31 Million USD | 1.75% |
| 2019 Q1 | 3.61 Million USD | 9.71% |
| 2019 Q2 | 3.26 Million USD | -9.79% |
| 2019 Q4 | 3.71 Million USD | 12.05% |
| 2019 FY | 13.91 Million USD | 22.81% |
| 2018 Q2 | 2.96 Million USD | 17.83% |
| 2018 FY | 11.33 Million USD | 54.11% |
| 2018 Q4 | 3.29 Million USD | 29.25% |
| 2018 Q3 | 2.55 Million USD | -14.05% |
| 2018 Q1 | 2.51 Million USD | 2.65% |
| 2017 Q3 | 1.59 Million USD | -14.46% |
| 2017 Q4 | 2.45 Million USD | 53.6% |
| 2017 FY | 7.35 Million USD | -48.29% |
| 2017 Q1 | 1.43 Million USD | -44.49% |
| 2017 Q2 | 1.86 Million USD | 30.01% |
| 2016 Q2 | 1.55 Million USD | -81.71% |
| 2016 FY | 14.22 Million USD | 64.2% |
| 2016 Q4 | 2.58 Million USD | 62.09% |
| 2016 Q3 | 1.59 Million USD | 2.84% |
| 2016 Q1 | 8.48 Million USD | 336.75% |
| 2015 Q1 | 1.68 Million USD | 14.12% |
| 2015 FY | 8.66 Million USD | 62.59% |
| 2015 Q4 | 1.94 Million USD | -33.34% |
| 2015 Q3 | 2.91 Million USD | 37.89% |
| 2015 Q2 | 2.11 Million USD | 25.16% |
| 2014 Q3 | 1.58 Million USD | 32.67% |
| 2014 Q2 | 1.19 Million USD | 12.75% |
| 2014 Q1 | 1.06 Million USD | 34.74% |
| 2014 FY | 5.32 Million USD | 61.33% |
| 2014 Q4 | 1.48 Million USD | -6.81% |
| 2013 FY | 3.3 Million USD | 22.03% |
| 2013 Q4 | 787.99 Thousand USD | -5.49% |
| 2013 Q1 | 696.24 Thousand USD | -20.14% |
| 2013 Q2 | 983.99 Thousand USD | 41.33% |
| 2013 Q3 | 833.76 Thousand USD | -15.27% |
| 2012 Q3 | - USD | 0.0% |
| 2012 FY | 2.7 Million USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q4 | 871.81 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 96.63 Million USD | 81.084% |
| AngioDynamics, Inc. | 303.91 Million USD | 93.985% |
| AtriCure, Inc. | 399.24 Million USD | 95.422% |
| Avinger, Inc. | 7.65 Million USD | -138.879% |
| Azenta, Inc. | 665.07 Million USD | 97.252% |
| BioLife Solutions, Inc. | 143.27 Million USD | 87.242% |
| The Cooper Companies, Inc. | 3.59 Billion USD | 99.491% |
| Daxor Corporation | 1.28 Million USD | -1327.473% |
| Femasys Inc. | 1.07 Million USD | -1605.178% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 112.25 Million USD | 83.716% |
| Hologic, Inc. | 4.03 Billion USD | 99.546% |
| ICU Medical, Inc. | 2.25 Billion USD | 99.191% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 99.743% |
| KORU Medical Systems, Inc. | 28.51 Million USD | 35.903% |
| LeMaitre Vascular, Inc. | 193.48 Million USD | 90.553% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -1486.059% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -1486.059% |
| Masimo Corporation | 2.04 Billion USD | 99.108% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 97.09 Million USD | 81.175% |
| Merit Medical Systems, Inc. | 1.25 Billion USD | 98.546% |
| Nephros, Inc. | 14.23 Million USD | -28.382% |
| NovoCure Limited | 509.33 Million USD | 96.411% |
| NEXGEL, Inc. | 4.08 Million USD | -347.029% |
| NEXGEL, Inc. | 4.08 Million USD | -347.029% |
| Singular Genomics Systems, Inc. | 2.91 Million USD | -527.929% |
| OraSure Technologies, Inc. | 405.47 Million USD | 95.492% |
| Pro-Dex, Inc. | 53.84 Million USD | 66.052% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 1.78 Million USD | -926.856% |
| Precision Optics Corporation, Inc. | 19.1 Million USD | 4.32% |
| QuidelOrtho Corporation | 2.99 Billion USD | 99.39% |
| Repligen Corporation | 638.76 Million USD | 97.138% |
| Sanara MedTech Inc. | 64.98 Million USD | 71.874% |
| STAAR Surgical Company | 322.41 Million USD | 94.331% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 50.22 Million USD | 63.605% |
| DENTSPLY SIRONA Inc. | 3.96 Billion USD | 99.539% |
| Jin Medical International Ltd. | 19.82 Million USD | 7.782% |